H. Moutsopoulos, Sj??c;gren's Syndrome: Autoimmune Epithelitis, Clinical Immunology and Immunopathology, vol.72, issue.2, pp.162-165, 1994.
DOI : 10.1006/clin.1994.1123

M. Gershwin, The mosaic of autoimmunity, Autoimmunity Reviews, vol.7, issue.3, pp.161-163, 2008.
DOI : 10.1016/j.autrev.2007.11.021

M. Christodoulou, E. Kapsogeorgou, and H. Moutsopoulos, Characteristics of the minor salivary gland infiltrates in Sj??gren's syndrome, Journal of Autoimmunity, vol.34, issue.4, pp.400-407, 2010.
DOI : 10.1016/j.jaut.2009.10.004

F. Arbonneau, J. Pers, V. Devauchelle, Y. Pennec, A. Saraux et al., BAFF-induced changes in B cell antigen receptor???containing lipid rafts in Sj??gren's syndrome, Arthritis & Rheumatism, vol.170, issue.1, pp.115-126, 2006.
DOI : 10.1002/art.21478

D. Stott, F. Hiepe, M. Hummel, G. Steinhauser, and C. Berek, Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sj??gren's syndrome., Journal of Clinical Investigation, vol.102, issue.5, pp.938-946, 1998.
DOI : 10.1172/JCI3234

S. Salomonsson, M. Jonsson, K. Skarstein, K. Brokstad, P. Hjelmström et al., Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sj??gren's syndrome, Arthritis & Rheumatism, vol.44, issue.11, pp.3187-3201, 2003.
DOI : 10.1002/art.11311

F. Barone, M. Bombardieri, A. Manzo, M. Blades, P. Morgan et al., Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sj??gren's syndrome, Arthritis & Rheumatism, vol.115, issue.6, pp.1773-1784, 2005.
DOI : 10.1002/art.21062

A. Hansen, P. Lipsky, and T. D?rner, Immunopathogenesis of primary Sj??gren??s syndrome: implications for disease management and therapy, Current Opinion in Rheumatology, vol.17, issue.5, pp.558-565, 2005.
DOI : 10.1097/01.bor.0000172801.56744.c3

D. Gor, N. Rose, and N. Greenspan, TH1-TH2: a Procrustean paradigm, Nature Immunology, vol.4, issue.6, pp.503-505, 2003.
DOI : 10.1038/ni0603-503

T. Mosmann and R. Coff-man, TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties, Annual Review of Immunology, vol.7, issue.1, pp.145-173, 1989.
DOI : 10.1146/annurev.iy.07.040189.001045

P. Miossec, T. Korn, and V. Kuchroo, Interleukin-17 and Type 17 Helper T Cells, New England Journal of Medicine, vol.361, issue.9, pp.888-898, 2009.
DOI : 10.1056/NEJMra0707449

S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono, Regulatory T Cells and Immune Tolerance, Cell, vol.133, issue.5, pp.775-787, 2008.
DOI : 10.1016/j.cell.2008.05.009

A. Saraux, The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sj??gren's syndrome, Autoimmunity Reviews, vol.9, issue.9, pp.609-614, 2010.
DOI : 10.1016/j.autrev.2010.05.007

P. Youinou, V. Devauchelle, and J. Pers, Significance of B cells and B cell clonality in Sj??gren's syndrome, Arthritis & Rheumatism, vol.52, issue.9, pp.2605-2610, 2010.
DOI : 10.1002/art.27564

D. Harris, L. Haynes, P. Sayles, D. Duso, S. Eaton et al., Reciprocal regulation of polarized cytokine production by eff ector B and T cells, Nature Immunology, vol.1, issue.6, pp.475-482, 2000.
DOI : 10.1038/82717

C. Jamin, A. Morva, S. Lemoine, C. Daridon, R. De-mendoza et al., Regulatory B lymphocytes in humans: A potential role in autoimmunity, Arthritis & Rheumatism, vol.54, issue.7, pp.1900-1906, 2008.
DOI : 10.1002/art.23487

F. Mackay, P. Silveira, and R. Brink, B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling, Current Opinion in Immunology, vol.19, issue.3, pp.327-336, 2007.
DOI : 10.1016/j.coi.2007.04.008

P. Szodoray, A. P. Brun, J. Centola, M. Jonsson, and R. , Circulating Cytokines in Primary Sjogren's Syndrome Determined by a Multiplex Cytokine Array System, Scandinavian Journal of Immunology, vol.54, issue.6, pp.592-599, 2004.
DOI : 10.1046/j.1365-3083.1998.00440.x

I. Crane and J. Forrester, Th1 and Th2 Lymphocytes in Autoimmune Disease, Critical Reviews in Immunology, vol.25, issue.2, pp.75-102, 2005.
DOI : 10.1615/CritRevImmunol.v25.i2.10

J. Hooks, H. Moutsopoulos, S. Geis, N. Stahl, J. Decker et al., Immune Interferon in the Circulation of Patients with Autoimmune Disease, New England Journal of Medicine, vol.301, issue.1, pp.5-8, 1979.
DOI : 10.1056/NEJM197907053010102

E. Hagiwara, J. Pando, Y. Ishigatsubo, and D. Klinman, Altered frequency of type-1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome, J Rheumatol, vol.25, pp.89-93, 1998.

D. Boumba, F. Skopouli, and H. Moutsopoulos, CYTOKINE mRNA EXPRESSION IN THE LABIAL SALIVARY GLAND TISSUES FROM PATIENTS WITH PRIMARY SJ??GREN'S SYNDROME, Rheumatology, vol.34, issue.4, pp.326-333, 1995.
DOI : 10.1093/rheumatology/34.4.326

E. Wakamatsu, I. Matsumoto, T. Yasukochi, Y. Naito, D. Goto et al., Overexpression of phosphorylated STAT-1?? in the labial salivary glands of patients with Sj??gren's syndrome, Arthritis & Rheumatism, vol.93, issue.11, pp.3476-3484, 2006.
DOI : 10.1002/art.22176

J. Van-woerkom, A. Kruize, M. Wenting-van-wijk, E. Knol, I. Bihari et al., Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjogren's syndrome compared with non-Sjogren's sicca syndrome, Annals of the Rheumatic Diseases, vol.64, issue.10, pp.1474-1479, 2005.
DOI : 10.1136/ard.2004.031781

D. Mitsias, A. Tzioufas, C. Veiopoulou, E. Zintzaras, I. Tassios et al., The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren???s syndrome, Clinical & Experimental Immunology, vol.72, issue.(Suppl. 1), pp.562-568, 2002.
DOI : 10.1046/j.1365-2249.2002.01869.x

M. Bombardieri, F. Barone, V. Pittoni, C. Alessandri, P. Conigliaro et al., Increased circulating levels and salivary gland expression of IL-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal infl ammatory infi ltrate, Arthritis Research & Therapy, vol.6, issue.5, pp.447-456, 2004.
DOI : 10.1186/ar1209

A. Sakai, Y. Sugawara, T. Kuroishi, T. Sasano, and S. Sugawara, Identification of IL-18 and Th17 Cells in Salivary Glands of Patients with Sjogren's Syndrome, and Amplification of IL-17-Mediated Secretion of Inflammatory Cytokines from Salivary Gland Cells by IL-18, The Journal of Immunology, vol.181, issue.4, pp.2898-2906, 2008.
DOI : 10.4049/jimmunol.181.4.2898

I. Mcinnes, J. Gracie, B. Leung, X. Wei, and F. Liew, Interleukin 18: a pleiotropic participant in chronic inflammation, Immunology Today, vol.21, issue.7, pp.312-315, 2000.
DOI : 10.1016/S0167-5699(00)01648-0

V. Dardalhon, T. Korn, V. Kuchroo, and A. Anderson, Role of Th1 and Th17 cells in organ-specific autoimmunity, Journal of Autoimmunity, vol.31, issue.3, pp.252-256, 2008.
DOI : 10.1016/j.jaut.2008.04.017

C. Nguyen, M. Hu, Y. Li, C. Stewart, and A. Peck, Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sj??gren's syndrome: Findings in humans and mice, Arthritis & Rheumatism, vol.54, issue.3, pp.734-743, 2008.
DOI : 10.1002/art.23214

M. Mitsdoerff-er, Y. Lee, A. Jäger, H. Kim, T. Korn et al., Proinflammatory T helper type 17 cells are effective B-cell helpers, Proceedings of the National Academy of Sciences, vol.107, issue.32, pp.14292-14297, 2010.
DOI : 10.1073/pnas.1009234107

G. Katsifi-s, S. Rekka, N. Moutsopoulos, S. Pillemer, and S. Wahl, Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sj??gren???s Syndrome Immunopathogenesis, The American Journal of Pathology, vol.175, issue.3, pp.1167-1177, 2009.
DOI : 10.2353/ajpath.2009.090319

T. Ito, S. Hanabuchi, Y. Wang, W. Park, K. Arima et al., Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and Periphery, Immunity, vol.28, issue.6, pp.870-880, 2008.
DOI : 10.1016/j.immuni.2008.03.018

J. Gottenberg, F. Lavie, K. Abbed, J. Gasnault, L. Nevot et al., CD4 CD25 regulatory T cells are not impaired in patients with primary Sj??gren's syndrome, Journal of Autoimmunity, vol.24, issue.3, pp.235-242, 2005.
DOI : 10.1016/j.jaut.2005.01.015

M. Liu, L. Lin, C. Weng, and M. Weng, Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sj??gren's syndrome, Lupus, vol.24, issue.1, pp.34-39, 2008.
DOI : 10.1177/0961203307085248

M. Christodoulou, E. Kapsogeorgou, N. Moutsopoulos, and H. Moutsopoulos, Foxp3+ T-regulatory cells in Sjögren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors

P. Youinou, &. Research, and . Therapy, http://arthritis-research.com/content, p.227227, 2011.

P. Youinou and C. Jamin, The weight of interleukin-6 in B cell-related autoimmune disorders, Journal of Autoimmunity, vol.32, issue.3-4, pp.206-210, 2009.
DOI : 10.1016/j.jaut.2009.02.013

N. Nishimoto and T. Kishimoto, Interleukin 6: from bench to bedside, Nature Clinical Practice Rheumatology, vol.28, issue.11, pp.619-626, 2006.
DOI : 10.1038/ncprheum0338

H. Hsu, P. Yang, J. Wang, Q. Wu, R. Myers et al., Interleukin 17???producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice, Nature Immunology, vol.1, issue.2, pp.166-175, 2008.
DOI : 10.1038/ni1552

L. Pottier, L. Devauchelle, V. Fautrel, A. Daridon, C. Saraux et al., Ectopic Germinal Centers Are Rare in Sjogren's Syndrome Salivary Glands and Do Not Exclude Autoreactive B Cells, The Journal of Immunology, vol.182, issue.6, pp.3540-3547, 2009.
DOI : 10.4049/jimmunol.0803588

S. Hillion, M. Dueymes, P. Youinou, and C. Jamin, IL-6 Contributes to the Expression of RAGs in Human Mature B Cells, The Journal of Immunology, vol.179, issue.10, pp.6790-6798, 2007.
DOI : 10.4049/jimmunol.179.10.6790

A. Kitani, M. Hara, T. Hirose, M. Harigai, K. Suzuki et al., Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression, Clinical & Experimental Immunology, vol.63, issue.Suppl. 1, pp.75-83, 1992.
DOI : 10.1111/j.1365-2249.1992.tb03042.x

A. Bikker, J. Van-woerkom, A. Kruize, M. Wenting-van-wijk, W. De-jager et al., Increased expression of interleukin-7 in labial salivary glands of patients with primary Sj??gren's syndrome correlates with increased inflammation, Arthritis & Rheumatism, vol.56, issue.Suppl, pp.969-977, 2010.
DOI : 10.1002/art.27318

D. Harris, S. Goodrich, K. Mohrs, M. Mohrs, and F. Lund, Cutting Edge: The Development of IL-4-Producing B Cells (B Effector 2 Cells) Is Controlled by IL-4, IL-4 Receptor ??, and Th2 Cells, The Journal of Immunology, vol.175, issue.11, pp.7103-7107, 2005.
DOI : 10.4049/jimmunol.175.11.7103

R. Ettinger, J. Browning, S. Michie, W. Van-ewijk, and H. Mcdevitt, Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-?? receptor-IgG1 fusion protein, Proceedings of the National Academy of Sciences, vol.93, issue.23, pp.13102-13107, 1996.
DOI : 10.1073/pnas.93.23.13102

P. Rennert, J. Browning, R. Mebius, F. Mackay, and P. Hochman, Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs, Journal of Experimental Medicine, vol.184, issue.5, pp.1999-2006, 1996.
DOI : 10.1084/jem.184.5.1999

F. Mackay, G. Majeau, P. Lawton, P. Hochman, and J. Browning, Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice, European Journal of Immunology, vol.16, issue.8, pp.2033-2042, 1997.
DOI : 10.1002/eji.1830270830

M. Gonzalez, F. Mackay, J. Browning, M. Kosco-vilbois, and R. Noelle, The Sequential Role of Lymphotoxin and B Cells in the Development of Splenic Follicles, The Journal of Experimental Medicine, vol.254, issue.7, pp.997-1007, 1998.
DOI : 10.1084/jem.185.12.2111

M. Gatumu, K. Skarstein, A. Papandile, J. Browning, R. Fava et al., Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sj??gren syndrome in salivary glands of non-obese diabetic mice, Arthritis Research & Therapy, vol.11, issue.1, p.24, 2009.
DOI : 10.1186/ar2617

L. Shen, L. Suresh, J. Wu, X. J. Li, H. Zhang et al., A Role for Lymphotoxin in Primary Sjogren's Disease, The Journal of Immunology, vol.185, issue.10, pp.6355-6363, 2010.
DOI : 10.4049/jimmunol.1001520

D. Durali, M. De-goër-de-herve, J. Giron-michel, B. Azzarone, and J. Delfraissy, In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment, Blood, vol.102, issue.12, pp.4084-4089, 2003.
DOI : 10.1182/blood-2003-02-0518

M. Manoussakis, S. Boiu, P. Korkolopoulou, E. Kapsogeorgou, N. Kavantzas et al., Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sj??gren's syndrome: Correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development, Arthritis & Rheumatism, vol.405, issue.12, pp.3977-3988, 2007.
DOI : 10.1002/art.23073

J. Vosters, M. Landek-salgado, H. Yin, W. Swaim, H. Kimura et al., Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sj????gren's syndrome, Arthritis & Rheumatism, vol.130, issue.12, pp.3633-3641, 2009.
DOI : 10.1002/art.24980

C. Daridon, T. Guerrier, V. Devauchelle, A. Saraux, J. Pers et al., Polarization of B effector cells in Sj??gren's syndrome, Autoimmunity Reviews, vol.6, issue.7, pp.427-431, 2007.
DOI : 10.1016/j.autrev.2007.01.010

A. Hansen, M. Odendahl, K. Reiter, A. Jacobi, E. Feist et al., Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sj??gren's syndrome, Arthritis & Rheumatism, vol.42, issue.Suppl, pp.2160-2171, 2002.
DOI : 10.1002/art.10445

A. Hansen, M. Gosemann, A. Pruss, K. Reiter, S. Ruzickova et al., Abnormalities in peripheral B cell memory of patients with primary Sj??gren's syndrome, Arthritis & Rheumatism, vol.416, issue.Suppl 1, pp.1897-1908, 2004.
DOI : 10.1002/art.20276

A. Hansen, C. Daridon, and T. D?rner, What do we know about memory B cells in primary Sj??gren's syndrome?, Autoimmunity Reviews, vol.9, issue.9, pp.600-603, 2010.
DOI : 10.1016/j.autrev.2010.05.005

A. Hansen, K. Reiter, T. Ziprian, A. Jacobi, A. Hoff-mann et al., Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sj??gren's syndrome, Arthritis & Rheumatism, vol.13, issue.7, pp.2109-2119, 2005.
DOI : 10.1002/art.21129

G. Xanthou, M. Polihronis, A. Tzioufas, S. Paikos, P. Sideras et al., ?Lymphoid? chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sj???gren's syndrome patients: Possible participation in lymphoid structure formation, Arthritis & Rheumatism, vol.168, issue.2, pp.408-418, 2001.
DOI : 10.1002/1529-0131(200102)44:2<408::AID-ANR60>3.0.CO;2-0

P. Salvatore, C. Pagliarulo, R. Colicchio, and C. Napoli, CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors, Current Medicinal Chemistry, vol.17, issue.27, pp.3019-3029, 2010.
DOI : 10.2174/092986710791959792

W. Zheng and R. Flavell, The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells, Cell, vol.89, issue.4, pp.587-596, 1997.
DOI : 10.1016/S0092-8674(00)80240-8

F. Mackay, P. Schneider, P. Rennert, and J. Browning, APRIL: A Tutorial on B Cell Survival, Annual Review of Immunology, vol.21, issue.1, pp.231-264, 2003.
DOI : 10.1146/annurev.immunol.21.120601.141152

J. Groom, S. Kalled, A. Cutler, C. Olson, S. Woodcock et al., Association of BAFF/BLyS overexpression and altered B cell differentiation with Sj??gren???s syndrome, Journal of Clinical Investigation, vol.109, issue.1, pp.59-68, 2002.
DOI : 10.1172/JCI0214121

M. Thien, T. Phan, S. Gardam, M. Amesbury, A. Basten et al., Excess BAFF Rescues Self-Reactive B Cells from Peripheral Deletion and Allows Them to Enter Forbidden Follicular and Marginal Zone Niches, Immunity, vol.20, issue.6, pp.785-798, 2004.
DOI : 10.1016/j.immuni.2004.05.010

P. Tengnér, A. Halse, H. Haga, R. Jonsson, and M. Wahren-herlenius, Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sj???gren's syndrome, Arthritis & Rheumatism, vol.83, issue.12, pp.2238-2248, 1998.
DOI : 10.1002/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V

V. Ngo, H. Korner, M. Gunn, K. Schmidt, D. Riminton et al., Lymphotoxin ??/?? and Tumor Necrosis Factor Are Required for Stromal Cell Expression of Homing Chemokines in B and T Cell Areas of the Spleen, The Journal of Experimental Medicine, vol.209, issue.2, pp.403-412, 1999.
DOI : 10.1084/jem.183.4.1461

C. Fletcher, A. Sutherland, J. Groom, M. Batten, L. Ng et al., Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells, European Journal of Immunology, vol.154, issue.9, pp.2504-2514, 2006.
DOI : 10.1002/eji.200636270

S. Lemoine, A. Morva, P. Youinou, and C. Jamin, Human T cells induce their own regulation through activation of B cells, Journal of Autoimmunity, vol.36, issue.3-4, pp.228-238, 2011.
DOI : 10.1016/j.jaut.2011.01.005

URL : https://hal.archives-ouvertes.fr/hal-00771265

S. Walters, K. Webster, A. Sutherland, S. Gardam, J. Groom et al., Increased CD4+Foxp3+ T Cells in BAFF-Transgenic Mice Suppress T Cell Effector Responses, The Journal of Immunology, vol.182, issue.2, pp.793-801, 2009.
DOI : 10.4049/jimmunol.182.2.793

J. Pers, F. Arbonneau, V. Devauchelle-pensec, A. Saraux, Y. Pennec et al., Is periodontal disease mediated by salivary baff in sj??gren's syndrome?, Arthritis & Rheumatism, vol.174, issue.8, pp.2411-2414, 2005.
DOI : 10.1002/art.21205

X. Mariette, S. Roux, J. Zhang, D. Bengoufa, F. Lavie et al., The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.62, issue.2, pp.168-171, 2003.
DOI : 10.1136/ard.62.2.168

S. Bosello, P. Youinou, C. Daridon, B. Tolusso, B. Bendaoud et al., Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis, J Rheumatol, vol.35, pp.1256-1264, 2008.

A. Becker-merok, C. Nikolaisen, and H. Nossent, B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time, Lupus, vol.17, issue.9, pp.570-576, 2006.
DOI : 10.1177/0961203306071871

E. Toubi, A. Kessel, I. Rosner, M. Rozenbaum, D. Paran et al., The Reduction of Serum B-Lymphocyte Activating Factor levels following Quinacrine Add-On Therapy in Systemic Lupus Erythematosus, Scandinavian Journal of Immunology, vol.23, issue.4, pp.299-303, 2006.
DOI : 10.1186/ar1222

P. Youinou and J. Pers, The late news on baff in autoimmune diseases, Autoimmunity Reviews, vol.9, issue.12, pp.804-806, 2010.
DOI : 10.1016/j.autrev.2010.06.011

URL : https://hal.archives-ouvertes.fr/hal-01150971

L. Pottier, L. Bendaoud, B. Renaudineau, Y. Youinou, P. Pers et al., New ELISA for B Cell-Activating Factor, Clinical Chemistry, vol.55, issue.10, pp.1843-1851, 2009.
DOI : 10.1373/clinchem.2009.129940

URL : https://hal.archives-ouvertes.fr/hal-01103760

L. Kwan-lam, Q. , K. H. Ko, O. Zheng, B. Lu et al., Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis, Proceedings of the National Academy of Sciences, vol.105, issue.39, pp.14993-14998, 2008.
DOI : 10.1073/pnas.0806044105

X. Li, Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling, Cytokine, vol.41, issue.2, pp.105-113, 2008.
DOI : 10.1016/j.cyto.2007.09.015

Y. Qian, J. Qin, G. Cui, M. Naramura, E. Snow et al., Act1, a Negative Regulator in CD40- and BAFF-Mediated B Cell Survival, Immunity, vol.21, issue.4, pp.575-587, 2004.
DOI : 10.1016/j.immuni.2004.09.001

P. Youinou, &. Research, and . Therapy, http://arthritis-research.com/content, p.227227, 2011.

Y. Qian, C. Liu, J. Hartupee, C. Altuntas, M. Gulen et al., The adaptor Act1 is required for interleukin 17???dependent signaling associated with autoimmune and inflammatory disease, Nature Immunology, vol.13, issue.3, pp.247-256, 2007.
DOI : 10.1074/jbc.273.7.4112

T. Lövgren, M. Eloranta, U. Båve, G. Alm, and L. Rönnblom, Induction of interferon-?? production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG, Arthritis & Rheumatism, vol.9, issue.8 Suppl, pp.1861-1872, 2004.
DOI : 10.1002/art.20254

C. Mavragani and M. Crow, Activation of the type I interferon pathway in primary Sjogren???s syndrome, Journal of Autoimmunity, vol.35, issue.3, pp.225-231, 2010.
DOI : 10.1016/j.jaut.2010.06.012

J. Gottenberg, N. Cagnard, C. Lucchesi, F. Letourneur, S. Mistou et al., Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome, Proceedings of the National Academy of Sciences, vol.103, issue.8, pp.2770-2775, 2006.
DOI : 10.1073/pnas.0510837103

Y. Renaudineau and P. Youinou, Epigenetics and Autoimmunity, with Special Emphasis on Methylation, The Keio Journal of Medicine, vol.60, issue.1, pp.10-16, 2011.
DOI : 10.2302/kjm.60.10

URL : https://hal.archives-ouvertes.fr/hal-00771236

C. Daridon, J. Pers, V. Devauchelle, C. Martins-carvalho, P. Hutin et al., Identification of transitional type II B cells in the salivary glands of patients with Sj??gren's syndrome, Arthritis & Rheumatism, vol.1050, issue.7, pp.2280-2288, 2006.
DOI : 10.1002/art.21936

C. Daridon, V. Devauchelle, P. Hutin, L. Berre, R. Martins-carvalho et al., Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sj??gren's syndrome, Arthritis & Rheumatism, vol.54, issue.4, pp.1134-1144, 2007.
DOI : 10.1002/art.22458

F. Van-de-veerdonk, B. Lauwerys, R. Marijnissen, K. Timmermans, D. Padova et al., The anti-CD20 antibody rituximab reduces the Th17 cell response, Arthritis & Rheumatism, vol.318, issue.6, pp.1507-1516, 2011.
DOI : 10.1002/art.30314

M. Varin, L. Pottier, L. Youinou, P. Saulep, D. Mackay et al., B-cell tolerance breakdown in Sj??gren's Syndrome: Focus on BAFF, Autoimmunity Reviews, vol.9, issue.9, pp.604-608, 2010.
DOI : 10.1016/j.autrev.2010.05.006

C. Kern, J. Cornuel, C. Billard, R. Tang, D. Rouillard et al., Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway, Blood, vol.103, issue.2, pp.679-688, 2004.
DOI : 10.1182/blood-2003-02-0540

T. D?rner, A. Radbruch, and G. Burmester, B-cell-directed therapies for autoimmune disease, Nature Reviews Rheumatology, vol.56, issue.8, pp.433-441, 2009.
DOI : 10.1038/nrrheum.2009.141

J. Pijpe, G. Van-imhoff, F. Spijkervet, J. Roodenburg, G. Wolbink et al., Rituximab treatment in patients with primary Sj??gren's syndrome: An open-label phase II study, Arthritis & Rheumatism, vol.44, issue.9, pp.2740-2750, 2005.
DOI : 10.1002/art.21260

V. Devauchelle-pensec, Y. Pennec, J. Morvan, J. Pers, C. Daridon et al., Saraux A: Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20) Arthritis Rheum, pp.310-317, 2007.

S. Dass, S. Bowman, E. Vital, K. Ikeda, C. Pease et al., Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study, Annals of the Rheumatic Diseases, vol.67, issue.11, pp.1541-1544, 2008.
DOI : 10.1136/ard.2007.083865

T. D?rner, A. Radbruch, and G. Burmester, B-cell-directed therapies for autoimmune disease, Nature Reviews Rheumatology, vol.56, issue.8, pp.433-441, 2009.
DOI : 10.1038/nrrheum.2009.141

P. Youinou, &. Research, and . Therapy, http://arthritis-research.com/content, p.227227, 2011.